Spruce Biosciences, Inc. Accrued Liabilities, Current
Spruce Biosciences, Inc. (SPRB) had Accrued Liabilities, Current of $7.25 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Accrued Liabilities, Current $7.25M.
- 2026-03-31: Accrued Liabilities, Current $8.10M.
- 2025-12-31: Accrued Liabilities, Current $9.14M.
- 2025-09-30: Accrued Liabilities, Current $7.50M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $7.25M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $8.10M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $9.14M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $7.50M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $6.31M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $12.44M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $12.33M 10-K · filed 2026-03-09 |
| 2024-09-30 | $7.74M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $10.68M 10-Q · filed 2024-08-12 |
| 2023-12-31 | $14.60M 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |